This study was designed to assess the effect of nebulized lignocaine or saline given before induction on the quality of induction of anaesthesia with desflurane in unpremedicated, young, adult males. Of the first six patients, five developed laryngospasm, breath-holding, coughing and increased secretions. In four patients oxygen saturation decreased to 92 % or less. Significant tachycardia and hypertension occurred in four patients, and bradyarrhythmia after induction occurred in three patients. Hiccups and bronchospasm occurred in one patient. Because of the unacceptably high incidence of complications, the study was discontinued. The incidence and severity of complications were not decreased by administration of nebulized lignocaine and were higher than those reported by other workers. We conclude that in unpremedicated, young, adult males, induction of anaesthesia with desflurane and nitrous oxide in oxygen was associated with a high incidence of respiratory irritant effects, tachycardia, hypertension and post-induction bradyarrhythmia. We also found that lignocaine, as used in this study, did not appear to obtund the cardiovascular and respiratory complications during inhalation induction using desflurane. (Br. J. Anaesth. 1995; 75: 631-633) 
Theoretically, desflurane should provide rapid induction and emergence from anaesthesia because of its low blood : gas solubility coefficient (0.42). However, it has been associated with irritation of the respiratory tract [1] and with hypertension and tachycardia [2] when used for inhalation induction. An increase in plasma catecholamines associated with a rapid increase in desflurane concentration beyond 1 MAC may account for this [3] . The mechanism for the catecholamine surge during desflurane anaesthesia is not understood, but irritation of the airways or lungs may be implicated. Nebulized lignocaine has been used to obtund the circulatory response to laryngoscopy and suppress airway irritation [4, 5] . Administration of lignocaine to the airway before induction of anaesthesia with desflurane may obtund the airway reflex responses and render induction smoother with respect to both respiratory and cardiovascular changes.
This study was designed to assess the effect of nebulized lignocaine on the quality of induction of anaesthesia with desflurane and 60 % nitrous oxide in oxygen.
Methods and results
After obtaining local Ethics Committee approval and written informed consent, we studied six ASA I male patients, aged 24-45 yr, undergoing day-case arthroscopy of the knee under general anaesthesia. Patients were excluded if they were 930% above or 920% below ideal body weight, allergic to study drugs, smoked within the previous year or were suspected to have a "difficult" airway.
Patients were unpremedicated. After cannulating a suitable vein, standard monitors were applied (EGG, arterial pressure, Patients were instructed to breathe through the mouth and to alternate two deep breaths and an inspiratory pause with three tidal breaths. Induction of anaesthesia was then immediately started using desflurane and 60 % nitrous oxide in oxygen (Ohmeda Tec 6 desflurane vaporizer and Ohmeda 5330 agent analyser). Desflurane was introduced at an inspired concentration of 3 % and increased by 3 % every 3-6 breaths as tolerated, up to a maximum of 12 %. Induction of anaesthesia was defined as complete when there was loss of verbal contact with the patient, loss of eyelash reflex, regular respiration and the eyes were immobile and central. and severe : requiring administration of suxamethonium; (4) breath-holding-each episode was recorded and graded: mild : :10 s, moderate : 10-20 s and severe : 920 s; (5) coughing-each episode was recorded and graded: mild : 1-3 coughs, moderate : 4-7 coughs and severe : 97 coughs; (6) secretions requiring removal by suction were recorded; (7) bronchospasm-the observer auscultated the chest at 1-min intervals; (8) hiccupseach episode was recorded; (9) purposeful movement of limbs-each episode was recorded and graded as mild, moderate or severe; (10) concentration of inspired desflurane when anaesthesia was induced; and (11) time to induction of anaesthesia.
There were three patients in each group. Patient data and cardiorespiratory changes are shown in table 1. Duration of induction in five patients was between 5 and 7.5 min, and in one patient was 11.25 min. The maximum inspired concentration of desflurane in all patients was 12 % and all tolerated insertion of the laryngeal mask airway. In five patients laryngospasm, breath-holding, coughing and increased secretions occurred. Oxygen saturation decreased to 92 % or less in four patients, although no patient required suxamethonium. Both hiccups and bronchospasm occurred in one patient. In the saline group, patient No. 1 became tachypnoeic (ventilatory frequency 990 b.p.m.) during induction. Significant sinus tachycardia (9100 beat min 91 ) occurred in four patients and significant hypertension (diastolic pressure 9100 mm Hg) in four patients. In the lignocaine group, patient No. 3 had a heart rate of 141 beats min 91 with a diastolic pressure of 140 mm Hg, and an oxygen saturation of 88 %; propofol 50 mg i.v. was administered. After induction of anaesthesia but before insertion of the arthroscope, when breathing 6 % desflurane for maintenance of anaesthesia, three patients developed bradyarrhythmia. In the saline group, in patient No. 1, the cardiac rhythm was unstable and changed from sinus to second-degree heart block (Mobitz type 2), to atrial bigeminy with first-degree heart block, to nodal, to sinus rhythm. Arterial pressure remained stable during the phase of arrhythmias and no treatment was required. Patient No. 2 in the saline group developed sinus bradycardia of 41 beat min 91 which responded to atropine 0.6 mg i.v. and patient No. 2 in the lignocaine group developed nodal bradycardia of 48 beat min 91 which resolved spontaneously. After operation patient No. 1 in the saline group remembered experiencing a severe shooting pain in his head as he was being anaesthetized, but on assessment after operation had no headache and no neurological deficit.
Because of an unacceptably high incidence and severity of cardiorespiratory responses the study was discontinued at this stage.
Comment
It is widely accepted that induction of anaesthesia with desflurane is associated with irritation of the respiratory tract and hypertension and tachycardia. During this study the frequency and severity of such complications were higher than those reported previously by other authors.
Rampil and colleagues [1] gave no other sedative drugs and anaesthesia was induced with desflurane until intubation without neuromuscular blocking drugs was possible. They found that induction required 10-18 min and that signs of minor, selflimiting airway irritation were apparent during induction, but clinically significant airway irritation was limited to two of 44 patients who. required suxamethonium for laryngospasm. Secretions (25-45 %) and coughing (38-56 %) were the commonest [6] administered i.v. fentanyl and a precurarization dose of tubocurarine before inhalation induction with desflurane. Suxamethonium was administered after induction of anaesthesia to facilitate tracheal intubation. In these studies the rate of increase in desflurane concentration was similar to that used in our study. These authors found that the duration of induction was approximately 2 min, and both described airway irritation, however, the frequency and severity were considerably less than we found. Both authors described individual patients who did not tolerate inhalation induction and were withdraw from the studies. Graham and Aitkenhead described tachycardia and Wrigley and colleagues described tachycardia and hypertension during induction, but again to a lesser degree than we encountered. In these studies induction was defined as complete when there was loss of consciousness, loss of eyelash reflex or loss of response to verbal commands. We found that the eyelash reflex and response to verbal commands were lost early during induction, before respiration was regular and before depth of anaesthesia was sufficient to permit insertion of the laryngeal mask, and that respiratory irritation was more marked towards the end of induction. The administration of sedative drugs, neuromuscular blockers and relatively early termination of induction may explain why these authors experienced fewer problems than us.
Previous authors have compared desflurane and propofol induction and found the incidence of sinus and nodal bradycardia to be similar with both techniques [2, 6] . Wrigley and colleagues found that bradycardia tended to occur towards the end of induction (of 60 patients, seven experienced sinus bradycardia (propofol three, desflurane four), and nine experienced a self-limiting nodal bradycardia (propofol five, desflurane four)). In these studies administration of fentanyl and suxamethonium may have contributed.
Definite conclusions cannot be drawn from this study because of the small numbers involved. However, we found that in unpremedicated, young, adult males, induction of anaesthesia with desflurane and nitrous oxide in oxygen was associated with an unacceptably high incidence of respiratory irritant effects, tachycardia, hypertension and post-induction bradyarrhythmia. We also found that nebulized lignocaine, as used here, did not appear to decrease the respiratory and cardiovascular responses during inhalation induction with desflurane.
